Integrated BioTherapeutic Vaccines, Inc. (IBV)

Integrated BioTherapeutic Vaccines, Inc. (IBV)

Integrated BioTherapeutic Vaccines, Inc. (IBV) is a wholly owned subsidiary of Integrated BioTherapeutics, Inc. (IBT).  IBV’s mission is to foster the successful development of IBT-V02 a multi-component vaccine against Staphylococcus aureus, in particular MRSA, and other vaccine products with investor funding in preparation of either licensing or forging strategic partnerships that lead to successful commercialization.

CORPORATE MISSION STATEMENT

Our mission is to develop innovative vaccines against invasive bacterial infections and to play a pivotal role in the fight against anti-microbial resistance.